A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β- peptide

Journal of Neurochemistry

Volumn 68, Issue 1, 1997, Pages 255-264

  Mark, Robert J ^a   Lovell, Mark A ^a   Markesbery, William R ^a,b   Uchida, Koji ^c   Mattson, Mark P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Excitatory amino acid; Free radicals; Glutathione; Hippocampal neurons; Na+,K+ ATPase

Indexed keywords

4 HYDROXYNONENAL; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMYLOID BETA PROTEIN; EXCITATORY AMINO ACID; FREE RADICAL; GLUTATHIONE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; EMBRYO; HIPPOCAMPUS; HOMEOSTASIS; LIPID PEROXIDATION; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031020476     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68010255.x     Document Type: Article

References (67)

1. 2+ accumulation. Proc. Natl. Acad. Sci. USA 92, 9328-9332.
2. Beal M. F. (1994) Neurochemistry and toxin models in Huntington's disease. Curr. Opin. Neurol. 7, 542-547.
3. Behl C., Davis J., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
4. 3 poisoning. Biochim. Biophys. Acta 711, 345-356.
5. Benedetti A., Fulceri R., and Comporti M. (1984) Inhibition of calcium sequestration activity of liver microsomes by 4-hydroxyalkenals originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta 793, 489-493.
6. Benzi G. and Moretti A. (1995) Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radic. Biol. Med. 19, 77-101.
7. Bhatnagar A. (1995) Electrophysiological effects of 4-hydroxynonenal, an aldehydic product of lipid peroxidation, on isolated rat ventricular myocytes. Circ. Res. 76, 293-304.
8. Busciglio J., Lorenzo A., Yeh J., and Yankner B. A. (1995) β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888.
9. Butterfield D. A., Hensley K., Harris M., Mattson M. P., and Carney J. (1994) β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200, 710-715.
10. Cai X.-D., Golde T. E., and Younkin S. G. (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514-516.
11. Cheng B. and Mattson M. P. (1992) Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF. Exp. Neurol. 117, 114-123.
12. Choi D. W. (1994) Glutamate receptors and the induction of excitotoxic neuronal death. Prog. Brain Res. 100, 47-51.
13. Dianzani M. U., Paradisi L., Barera G., Rossi M. A., and Parola M. (1989) The action of 4-hydroxynonenal on the plasma membrane enzymes from rat hepatocytes, in Free Radicals, Metal Ions and Biopolymers (Beumont P. C. et al., eds), pp. 329-346. Richelieu Press, London.
14. Esterbauer H., Zollner H., and Scholz N. (1975) Reaction of glutathione with conjugated carbonyls. Z. Naturforsch. 30, 466-473.
15. Esterbauer H., Jurgens G., Quehenberger O., and Koller E. (1987) Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28, 495-509.
16. Esterbauer H., Schaur R. J., and Zollner H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81-128.
17. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., McConlogue S., Montoya-Zavalal M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., and Zhao J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717V β-amyloid precursor protein. Nature 373, 523-527.
18. Goodman Y. and Mattson M. P. (1994) Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128, 1-12.
19. Goodman Y. and Mattson M. P. (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J. Neurochem. 66, 869-872.
20. Griffith O. W. and Meister A. (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem. 254, 7558-7560.
21. Grynkiewicz G., Poenie M., and Tsien R. Y. (1985) A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
22. Hartley D. P., Ruth J. A., and Petersen D. R. (1995) The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione 5-transferase. Arch. Biochem. Biophys. 316, 197-205.
23. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R., and Butterfield D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91, 3270-3274.
24. Jurgens G., Lang J., and Esterbauer H. (1986) Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochim. Biophys. Acta 875, 103-114.
25. Jurgens G., Chen Q., Esterbauer H., Mair S., Ledinski G., and Dinges H. P. (1993) Atherogenic lipoproteins in man: immunostaining of human autopsy aorta with antibodies to modified apolipoprotein B and apolipoprotein (a). Arterioscler. Thromb. 13, 1689-1699.
26. Kaneko T., Kaji K., and Matsuo M. (1988) Cytotoxicities of a linoleic acid hydroperoxide and its related aliphatic aldehydes toward cultured umbilical vein endothelial cells. Chem. Biol. Interact. 67, 295-304.
27. Kelly J., Furukawa K., Barger S. W., Mark R. J., Rengen M. R., Blanc E. M., Roth G. S., and Mattson M. P. (1996) Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. USA 93, 6753-6758.
28. +-ATPase. Am. J. Physiol. 252, H252-H257.
29. Koh J.-Y., Yang L. L., and Cotman C. W. (1990) β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533, 315-320.
30. Lorenzo J.-Y. and Yankner B. A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91, 12243-12247.
31. Lovell M. A., Ehmann W. D., Butler S. M., and Markesbery W. R. (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
32. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
33. Mark R. J., Blanc E. M., and Mattson M. P. (1996) Amyloid β-peptide and oxidative cell injury in Alzheimer's disease. Mol. Neurobiol. 12, 211-224.
34. Martelli A., Canonero R., Cavanna M., Ceradelli M., and Marinari U. M. (1994) Cytotoxic and genotoxic effects of five n-alkanals in primary cultures of rat and human hepatocytes. Mutat. Res. 323, 121-126.
35. Mattson M. P. (1990) Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and calcium influx in cultured hippocampal neurons. Neuron 4, 105-117.
36. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 379-389.
37. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-414.
38. Mattson M. P., Tomaselli K., and Rydel R. E. (1993b) Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49.
39. Mattson M. P., Barger S. W., Begley J. G., and Mark R. J. (1995) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46, 187-216.
40. Mattson M. P., Furukawa K., Bruce A. J., Mark R. J., and Blanc E. (1996) Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia, in Molecular Models of Dementia (Tanzi R. E. and Wasco W., eds), in press. Humana Press, Totowa, New Jersey.
41. Montine T. J., Amaranth V., Martin M. E., Strittmatter W. J., and Graham D. G. (1996) E-4-Hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol 148, 89-93.
42. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival. J. Immunol. Methods 65, 55-63.
43. Mullan M. and Crawford F. (1993) Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16, 398-403.
44. Palinski W., Rosenfeld M. E., Yla-Herttuala S., Gurtner G. C., Socher S. A., Butler S., Parthasarathy S., Carew T. E., Steinberg D., and Witztum J. L. (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86, 1372-1376.
45. Palinski W., Yla-Herttuala S., Rosenfeld M. E., Butler S. W., Socher S. A., Parthasarathy S., Curtiss L. K., and Witztum J. L. (1990) Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10, 325-335.
46. Palinski W., Ord V. A., Plump A. S., Breslow J. L., Steinberg D., and Witztum J. L. (1994) ApoE-deficient mice are a model of lipoprotein oxidation in atherosclerosis. Arterioscler. Thromb. 14, 605-616.
47. Rohn T. T., Hinds T. R., and Vincenzi F. F. (1993) Ion transport ATPases as targets for free radical damage. Chem. Pharmacol. 46, 525-534.
48. Rosenfeld M. E., Palinski W., Yla-Herttuala S., Butler S., and Witztum J. L. (1990) Distribution of oxidation-specific lipid-protein adducts and apolipoprotcin B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 10, 336-349.
49. Rothstein J. D. and Kuncl R. W. (1995) Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J. Neurochem. 65, 643-651.
50. +-ATPase. Free Radic. Biol. Med. 20, 215-223.
51. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., and Markesbery W. R. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88, 10540-10543.
52. Smith M. A., Taneda S., Richey P. L., Miyata S., Yan S.-D., Stern D., Sayre L. M., Monnier V. M., and Perry G. (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA 91, 5710-5714.
53. Smith M. A., Sayre L. M., Monnier V. M., and Perry G. (1995) Radical ageing in Alzheimer's disease. Trends Neurosci. 18, 172-176.
54. 2-resistant cell lines. Do aldehyde by-products of lipid peroxidation contribute to oxidative stress? Biochem. J. 267, 453-459.
55. Stein-Behrens B., Mattson M. P., Chang I., Yeh M., and Sapolsky R. M. (1994) Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 14, 5373-5380.
56. Toyokuni K., Uchida K., Okamoto K., Hattori-Nakakuki Y., Hiai H., and Stadtman E. R. (1994) Formation of 4-hydroxy-2-nonenal-modified proteins in renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl. Acad. Sci. USA 91, 2116-2120.
57. Uchida K. and Stadtman E. R. (1992) Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc. Natl. Acad. Sci. USA 89, 4544-4548.
58. Uchida K. and Stadtman E. R. (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 268, 6388-6393.
59. Uchida K. and Stadtman E. R. (1994) Quantitation of 4-hydroxynonenal protein adducts. Methods Enzymol. 233, 371-380.
60. Uchida K., Szweda L. I., Chae H. Z., and Stadtman E. R. (1993) Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc. Natl. Acad. Sci. USA 90, 8742-8746.
61. Uchida K., Toyokuni S., Nishikawa K., Kawakishi S., Oda H., Hiai H., and Stadtman E. R. (1994) Michael addition-type-4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry 33, 12487-12494.
62. Uchida K., Osawa T., Hiai H., and Toyokuni S. (1995) 4-Hydroxy-2-nonenal-trapping ELISA: direct evidence for the release of a cytotoxic aldehyde from oxidized low density lipoproteins. Biochem. Biophys. Res. Commun. 212, 1068-1073.
63. Vitek M. P., Bhattacharya K., Glendening J. M., Stopa E., Vlassara H., Bucala R., Manogue K., and Cerami A. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 4766-4770.
64. Volterra A., Trotti D., Tromba C., Floridi S., and Racagni G. (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 2924-2932.
65. Yankner B. A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
66. Yankner B. A., Duffy L. K., and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279-282.
67. Yoshino K., Matsuura T., Sano M., Saito S.-I., and Tomita I. (1986) Fluorometric liquid chromatographic determination of aliphatic aldehydes arising from lipid peroxides. Chem. Pharm. Bull. (Tokyo) 34, 1694-1700.